INTA Systems secures a €350,000 seed investment from Eureka! and A11 Venture to commercialize its innovative lab-on-a-chip technology for rapid diagnostics.

Target Information

INTA Systems is the inaugural spin-off of the NEST Laboratory, associated with the Scuola Normale Superiore University of Pisa and the National Research Council of Italy (CNR-NANO). Established in April 2020, INTA has quickly garnered attention for its groundbreaking lab-on-a-chip innovation, known as BRAIKER. This portable device is designed for the rapid detection of biomarkers related to traumatic brain injuries through blood analysis. Additionally, the technology promises versatility with future applications in detecting viruses and bacteria, highlighting its broad potential in molecular diagnostics.

Founded by a distinguished team of researchers, including Matteo Agostini, Marco Cecchini, and Marco Calderisi, INTA Systems aims to revolutionize high-end portable diagnostics. The firm recently secured its initial seed investment of €350,000 from Eureka! and A11 Venture to bring its technology to market. This funding will facilitate the transition from academic research to commercial application, expanding opportunities for growth in the biotech sector.

Industry Overview in Italy

Italy's biotechnology sector is thriving, characterized by innovative breakthroughs and an emphasis on research and development. The country is recognized for its strong academic institutions, such as the Scuola Normale Superiore and CNR-NANO, which